Jie-Ying Kowa1, Neil Soneji1, S Aslam Sohaib1, Erik Mayer2,3, Stephen Hazell4, Nicholas Butterfield1, Joshua Shur1, Derfel Ap Dafydd1. 1. Department of Radiology, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK. 2. Department of Surgery, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK. 3. Department of Surgery & Cancer, St Mary's Hospital Campus, Imperial College London, Praed Street, London, UK. 4. Department of Histopathology, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
Abstract
OBJECTIVE: We determined the sensitivity and specificity of multiparametric magnetic resonance imaging (MP-MRI) in detection of locally recurrent prostate cancer and extra prostatic extension in the post-radical radiotherapy setting. Histopathological reference standard was whole-mount prostatectomy specimens. We also assessed for any added value of the dynamic contrast enhancement (DCE) sequence in detection and staging of local recurrence. METHODS: This was a single centre retrospective study. Participants were selected from a database of males treated with salvage prostatectomy for locally recurrent prostate cancer following radiotherapy. All underwent pre-operative prostate-specific antigen assay, positron emission tomography CT, MP-MRI and transperineal template prostate mapping biopsy prior to salvage prostatectomy. MP-MRI performance was assessed using both Prostate Imaging-Reporting and Data System v. 2 and a modified scoring system for the post-treatment setting. RESULTS: 24 patients were enrolled. Using Prostate Imaging-Reporting and Data System v. 2, sensitivity, specificity, positive predictive value and negative predictive value was 64%, 94%, 98% and 36%. MP-MRI under staged recurrent cancer in 63%. A modified scoring system in which DCE was used as a co-dominant sequence resulted in improved diagnostic sensitivity (61%-76%) following subgroup analysis. CONCLUSION: Our results show MP-MRI has moderate sensitivity (64%) and high specificity (94%) in detecting radio-recurrent intraprostatic disease, though disease tends to be under quantified and under staged. Greater emphasis on dynamic contrast images in overall scoring can improve diagnostic sensitivity. ADVANCES IN KNOWLEDGE: MP-MRI tends to under quantify and under stage radio-recurrent prostate cancer. DCE has a potentially augmented role in detecting recurrent tumour compared with the de novo setting. This has relevance in the event of any future modified MP-MRI scoring system for the irradiated gland.
OBJECTIVE: We determined the sensitivity and specificity of multiparametric magnetic resonance imaging (MP-MRI) in detection of locally recurrent prostate cancer and extra prostatic extension in the post-radical radiotherapy setting. Histopathological reference standard was whole-mount prostatectomy specimens. We also assessed for any added value of the dynamic contrast enhancement (DCE) sequence in detection and staging of local recurrence. METHODS: This was a single centre retrospective study. Participants were selected from a database of males treated with salvage prostatectomy for locally recurrent prostate cancer following radiotherapy. All underwent pre-operative prostate-specific antigen assay, positron emission tomography CT, MP-MRI and transperineal template prostate mapping biopsy prior to salvage prostatectomy. MP-MRI performance was assessed using both Prostate Imaging-Reporting and Data System v. 2 and a modified scoring system for the post-treatment setting. RESULTS: 24 patients were enrolled. Using Prostate Imaging-Reporting and Data System v. 2, sensitivity, specificity, positive predictive value and negative predictive value was 64%, 94%, 98% and 36%. MP-MRI under staged recurrent cancer in 63%. A modified scoring system in which DCE was used as a co-dominant sequence resulted in improved diagnostic sensitivity (61%-76%) following subgroup analysis. CONCLUSION: Our results show MP-MRI has moderate sensitivity (64%) and high specificity (94%) in detecting radio-recurrent intraprostatic disease, though disease tends to be under quantified and under staged. Greater emphasis on dynamic contrast images in overall scoring can improve diagnostic sensitivity. ADVANCES IN KNOWLEDGE: MP-MRI tends to under quantify and under stage radio-recurrent prostate cancer. DCE has a potentially augmented role in detecting recurrent tumour compared with the de novo setting. This has relevance in the event of any future modified MP-MRI scoring system for the irradiated gland.
Authors: Andrew B Rosenkrantz; Luke A Ginocchio; Daniel Cornfeld; Adam T Froemming; Rajan T Gupta; Baris Turkbey; Antonio C Westphalen; James S Babb; Daniel J Margolis Journal: Radiology Date: 2016-04-01 Impact factor: 11.105
Authors: Anna Luzurier; Paul-Hugo Jouve De Guibert; Alexandre Allera; Sarah F Feldman; Pierre Conort; Jean Marc Simon; Pierre Mozer; Eva Compérat; Franck Boudghene; Vincent Servois; Olivier Lucidarme; Benjamin Granger; Raphaele Renard-Penna Journal: J Magn Reson Imaging Date: 2018-03-08 Impact factor: 4.813
Authors: Olivio F Donati; Sung Il Jung; Hebert Alberto Vargas; David H Gultekin; Junting Zheng; Chaya S Moskowitz; Hedvig Hricak; Michael J Zelefsky; Oguz Akin Journal: Radiology Date: 2013-03-12 Impact factor: 11.105
Authors: R Schiavina; F Ceci; M Borghesi; E Brunocilla; V Vagnoni; M Gacci; P Castellucci; C Nanni; G Martorana; S Fanti Journal: Curr Radiopharm Date: 2013-06-06
Authors: Andrei S Purysko; Leonardo K Bittencourt; Jennifer A Bullen; Thomaz R Mostardeiro; Brian R Herts; Eric A Klein Journal: AJR Am J Roentgenol Date: 2017-06-01 Impact factor: 3.959
Authors: A El-Shater Bosaily; C Parker; L C Brown; R Gabe; R G Hindley; R Kaplan; M Emberton; H U Ahmed Journal: Contemp Clin Trials Date: 2015-03-03 Impact factor: 2.226
Authors: Catarina Dinis Fernandes; Ghazaleh Ghobadi; Henk G van der Poel; Jeroen de Jong; Stijn W T P J Heijmink; Ivo Schoots; Iris Walraven; Petra J van Houdt; Milena Smolic; Floris J Pos; Uulke A van der Heide Journal: Eur Radiol Date: 2018-11-12 Impact factor: 5.315